pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,898 catalysts · 5,256 phase readout · 2,298 8k filing · 341 pdufa · 255 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,298
  • pdufa341
  • earnings255
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07057921: The Learning Curve of Video Laryngeal Mask Airway (Video-LMA) Use in Airway Management by Anesthesiology Residents

Sponsor: Samsun University. Phase: . Conditions: Laryngeal Mask Airways, Airway Devices

full page →ctgov ↗
›RECRUITINGphase readoutNCT07374614: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Sponsor: Peking University Shenzhen Hospital. Phase: . Conditions: Non-Small Cell Lung Cancer, ALK, Iruplinalkib, Lorlatinib, Real-world Study, Observational Study

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07442214: View of Cerebral Perfusion in Liver Transplantation

Sponsor: Inonu University. Phase: . Conditions: End-stage Liver Disease (ESLD), Liver Transplantation, Cerebral Perfusion, Intraoperative Monitoring

full page →ctgov ↗
›COMPLETEDphase readoutNCT02957916: Vanderbilt Childhood Obesity Registry

Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Childhood Onset Obesity, Pediatric Obesity, Childhood Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394816: Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Postoperative Pulmonary Complications (PPCs), Abdominal Surgeries, Postoperative Pain Management

full page →ctgov ↗
›RECRUITINGphase readoutNCT05482906: Common and Specific Information From Neuroimaging and Smartphone

Sponsor: Nantes University Hospital. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06910306: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Sponsor: Alpha Tau Medical LTD.. Phase: NA. Conditions: Recurrent Glioblastoma, Recurrent Gliomas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07543484: Kinematics and Muscle Activity During the Tennis Serve and Musculoskeletal Characteristics in Tennis Players With Subacromial Pain Syndrome or History of Shoulder Pain

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Shoulder Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07486505: Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, Mindfulness-based Intervention to Manage Pain and Anxiety Before and After Fracture Surgery

Sponsor: McMaster University. Phase: NA. Conditions: Orthopaedic Fractures, Orthopaedic Trauma Fractures and Non-unions, Orthopaedic Trauma, Orthopaedic Surgery, Orthopaedic Related Pain (Musculoskeletal Pain), Anxiety Acute, Anxiety After Surgery, Opioid Use, Opioid Use After Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07195994: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Sponsor: QuickSilver Scientific. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07504094: Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Chronic Back Pain, Chronic Pain, Back Pain, Low Back Pain, Chronic, Musculoskeletal Pain, Kinesiophobia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02616666: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Sponsor: University of Liverpool. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07206056: An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Progressive Metastatic Castrate Resistant Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00092222: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07556822: Phase I Study of HRS-3005 in B-cell Malignancies

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: B-cell Malignancy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06368622: Evolve China PMCF Study

Sponsor: Stryker Neurovascular. Phase: . Conditions: Intracranial Aneurysm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06835751: Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: HIV, Mental Health, Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05397951: The Validation Study of Bioelectronics

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Healthy, Health Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT07142551: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07089329: Efficacy of Striatin in Malnourished Children

Sponsor: Universitas Sriwijaya. Phase: PHASE3. Conditions: Severe Acute Malnutrition

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504029: Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides

Sponsor: Chung Shan Medical University. Phase: NA. Conditions: People With Prediabetic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07378553: Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies

Sponsor: Nantes University Hospital. Phase: . Conditions: Duchene Muscular Dystrophy, Becker Muscular Dystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07410637: Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Sponsor: University of Ulm. Phase: NA. Conditions: Graves Disease, Thyroid Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03093337: Psychomotor Therapy for Very Premature Infants

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06476145: Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Sponsor: AdventHealth. Phase: . Conditions: Adenoma Colon Polyp

full page →ctgov ↗
›RECRUITINGphase readoutNCT06665295: THRIVE-CAR-T Digital App

Sponsor: Patrick C. Johnson, MD. Phase: NA. Conditions: CAR T-Cell Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07124377: Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Sponsor: Hospital 9 de Julio de Las Breñas. Phase: . Conditions: Hereditary Amyloidosis, Transthyretin-Related

full page →ctgov ↗
›COMPLETEDphase readoutNCT04985877: Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota in Sarcopenia Elderly

Sponsor: Taipei Medical University. Phase: NA. Conditions: Sarcopenia, Inflammation, Aging

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07477977: Dose for Reversal of Heparin After Cardiopulmonary Bypass

Sponsor: Sohag University. Phase: NA. Conditions: Open Heart Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06077877: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT07313475: Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Lupus Anticoagulant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06623357: Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. Phase: NA. Conditions: Brachial Plexus Birth Palsy, Erbs Palsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06267001: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06608901: A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Sepsis-Induced Hypotension

full page →ctgov ↗
›COMPLETEDphase readoutNCT05423912: Keeping on Course: A Communication-Focused Psychoeducational Program

Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03500081: Solid Tumor Imaging MR-Linac (STIM Study)

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07388719: Comparison of Standard Versus Dynamic Compliance-Guided Individualized PEEP in Obese Patients Undergoing Spinal Surgery

Sponsor: Konya City Hospital. Phase: NA. Conditions: Obesity, Postoperative Pulmonary Complications, Mechanical Ventilation

full page →ctgov ↗
›COMPLETEDphase readoutNCT04238819: A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Relapsed Solid Tumor, Refractory Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07416630: Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Gynecologic Cancer, Urologic Cancer, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06028828: Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor: University of California, Irvine. Phase: PHASE2. Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03178617: High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoblastic Lymphoma, Acute Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07351240: The Acupuncture Treatment Effect in Patients With Schizophrenia

Sponsor: Calo Psychiatric Center. Phase: NA. Conditions: Mental Health

full page →ctgov ↗
›COMPLETEDphase readoutNCT05968989: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Influenza

full page →ctgov ↗
›COMPLETEDphase readoutNCT05658068: Systems Aligning for Equity (SAFE) Spaces

Sponsor: New York University. Phase: NA. Conditions: Suicide, Mental Disorder, Mental Health, Burnout, Professional, Self Harm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07401550: Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

Sponsor: University College Dublin. Phase: . Conditions: Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery Disease (CAD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07415291: CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis

Sponsor: Istanbul Training and Research Hospital. Phase: . Conditions: Solitary Skin Lesions, Skin Neoplasms, Skin Neoplasm Malignant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06788691: Luspatercept for Clonal Cytopenias of Uncertain Significance

Sponsor: Weill Medical College of Cornell University. Phase: PHASE2. Conditions: CCUS Clonal Cytopenia of Undetermined Significance, Anemia, Leukopenia, Thrombocytopenia, Neutropenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07201974: Virtual Reality for Post-Stroke Gait Rehabilitation

Sponsor: McGill University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03360890: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

Sponsor: University of Chicago. Phase: PHASE2. Conditions: Thyroid Cancer, Salivary Gland Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07425197: Comparative Effects of Two Rehabilitation Approaches on Lumbopelvic Function in Sacroiliac Joint Dysfunction

Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Sacroiliac Joint Dysfunction

full page →ctgov ↗
← prev
page 63 of 158
next →